Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGF beta Signaling Pathway in Breast Cancer Cells

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 21 巻 3 号 2020-02 発行
アクセス数 : 1005
ダウンロード数 : 0

今月のアクセス数 : 29
今月のダウンロード数 : 0
タイトル
Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGF beta Signaling Pathway in Breast Cancer Cells
著者
Li Shaolan
Fan Yang
Kumagai Asako
Kawakita Emi
Kitada Munehiro
Koya Daisuke
収録物名
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
21
3
収録物識別子
EISSN 1422-0067
主題
DPP-4; EMT; chemoresistance; ABC transporters; apoptosis; breast cancer ( その他)
言語
英語
資源タイプ 学術雑誌論文
出版者
MDPI
発行日 2020-02
アクセス権 メタデータのみ
関連情報
[DOI] 10.3390/ijms21030805
[PMID] 31991851
備考 Authors declare there is no conflict interest with this study. This study was partially supported by grants from the Japan Society for the Promotion of Science awarded to KK (19K08738) and DK (16K15472). This study was partially supported by a Grant for Promoted Research awarded to KK (K2018-28) from Kanazawa Medical University. S.L. is supported by foreign scholar grants from Kanazawa Medical University. Boehringer Ingelheim (Japan), MitsubishiTanabe Pharma and Ono Pharmaceutical, Taisho Pharmaceutical, Kyowa-Hakko Kirin contributed to establishing the Division of Anticipatory Molecular Food Science and Technology. KK is under a consultancy agreement with Boehringer Ingelheim.